Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private biotech companies. Experience the best of biotech with two days of productive partnering meetings with institutional and early-stage investors, industry analysts, and senior biotechnology executives, in one location.
Over 340 investors have already registered, including ARCH Venture Partners, New Enterprise Associates, Sofinnova Ventures, and SR One, who are currently active in the partnering system and read to meet! Partnering activity is breaking records, with total meeting requests up 36% and accepted requests pacing 23% ahead of 2019.
This year’s panelists represent the industry’s who’s who of business thought leaders, clinical innovators and financial market experts. Session topics will cover advances in gene, liver, and cardiovascular disease therapies, developing an inclusive workforce, the global economy (policy and market outlooks).
- BIO One-on-One Partnering
- 13-minute presentation to showcase your pipeline
- Full programming: Panels and Fireside Chats
- Welcome reception
- Conference meals and coffee service
Approximately 150 companies have been hand-selected to showcase their pipelines, licensing and investment goals, including Newron Pharmaceuticals, XyloCor Therapeutics, Anima Biotech, and Greenwich LifeSciences, plus our Buzz of BIO winners: Breakthrough Genomics, AZTherapies, and Brainstorm Cell Therapeutics. View them here.